Department of Radiology, Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Lymphat Res Biol. 2021 Dec;19(6):531-538. doi: 10.1089/lrb.2020.0101. Epub 2021 Jan 21.
To demonstrate the value of intranodal lymphangiography (INL) and lymphatic embolization (LE) in management of iatrogenic chylous ascites in children who fail conservative management. Retrospective review of medical records revealed six patients (four males and two females; age range 11-39 months) who underwent eight INLs and three LEs between 2017 and 2019. In one patient, the leak was visualized and embolized. In three patients, the leak was not visualized and no embolization was done, but drain output decreased and INL was not repeated. In two patients, the leak was not visualized and no embolization was done, but drain output did not decrease and INL was repeated. Repeat INL identified a leak in one patient and targeted LE was done. Repeat INL did not identify a leak in the other patient, but empirical LE was performed at the sites suspicious for leakage after multidisciplinary discussion. INL was able to identify the site of lymphatic leak in two patients (33%). In the three patients who underwent LE (two targeted at the site of identified leak and one empirical at sites suspicious for leak), one (33%) was clinically successful and the other two required surgery to address the lymphatic leak. In three patients, chylous ascites resolved after INL alone with no additional interventions. Three patients developed complications after the procedure, but only one appears to be related to the procedure itself. Follow-up for 13.8 months (13-26 months) revealed no long-term complications or mortality. INL with or without LE is a safe treatment for iatrogenic pediatric chylous ascites. Early utilization before more invasive surgical intervention should be considered in light of the response to INL.
为了证明在保守治疗失败的儿童医源性乳糜性腹水患者中,淋巴结内淋巴管造影(INL)和淋巴栓塞(LE)在治疗中的价值。回顾性分析了 2017 年至 2019 年期间接受 8 次 INL 和 3 次 LE 治疗的 6 名患者(4 名男性和 2 名女性;年龄 11-39 个月)的病历。在 1 名患者中,观察到并栓塞了漏口。在 3 名患者中,未观察到漏口,也未进行栓塞,但引流液减少,未重复进行 INL。在 2 名患者中,未观察到漏口,也未进行栓塞,但引流液未减少,重复进行 INL。重复 INL 在 1 名患者中发现漏口,并进行了靶向 LE。在另一名患者中,重复 INL 未发现漏口,但在多学科讨论后,在疑似漏口部位进行了经验性 LE。INL 能够确定 2 名患者(33%)的淋巴漏部位。在接受 LE 治疗的 3 名患者中(2 名靶向已确定漏口部位,1 名靶向疑似漏口部位),1 名(33%)患者临床成功,另外 2 名患者需要手术解决淋巴漏问题。在 3 名患者中,单独进行 INL 后乳糜性腹水得到解决,无需进一步干预。3 名患者在手术后出现并发症,但只有 1 例似乎与手术本身有关。随访 13.8 个月(13-26 个月)未发现长期并发症或死亡。INL 联合或不联合 LE 是治疗医源性小儿乳糜性腹水的一种安全方法。鉴于 INL 的反应,在更具侵入性的手术干预之前,应考虑尽早使用。